Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia
- PMID: 21646917
- DOI: 10.1097/MPH.0b013e31820d86f2
Long-term neurocognitive outcomes in young adult survivors of childhood acute lymphoblastic leukemia
Abstract
Five-year survival rates of childhood acute lymphoblastic leukemia (ALL) exceed 80% due to central nervous system-directed treatment including cranial radiation (CRT) and chemotherapy. However, these treatments are associated with neurocognitive compromise, the extent of which is correlated with higher dose and younger age at treatment. The aims of this study were to explore long-term neurocognitive outcomes in adult survivors of childhood ALL, and to identify measures sensitive to neurotoxicity in long-term survivors. We examined 24 adults who received 18 Gy CRT and chemotherapy for treatment of ALL between ages 2 and 15 years (median, 5.5). Time since diagnosis ranged from 6 to 26 years (median, 16.6). Younger age at diagnosis and longer time since diagnosis were associated with lower scores on a computerized battery that requires speed and accuracy across a number of domains (MicroCog), and other standardized neurocognitive tests. When compared with population norms, MicroCog indices were below average in survivors diagnosed with ALL before age 5, but only the reasoning/calculation index was below average in survivors diagnosed with ALL after age 5. In contrast, intelligence quotient (IQ) scores were average. In addition to confirming earlier studies showing that younger children are more vulnerable to treatment-related neurotoxicity, here we show that deficits exist many years post treatment even with a relatively lower dose of CRT, and that these deficits are especially evident on tasks involving rapid processing of information.
Similar articles
-
Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.Pediatr Blood Cancer. 2009 Aug;53(2):156-61. doi: 10.1002/pbc.21992. Pediatr Blood Cancer. 2009. PMID: 19405135
-
Comparison of long-term neurocognitive outcomes in young children with acute lymphoblastic leukemia treated with cranial radiation or high-dose or very high-dose intravenous methotrexate.J Clin Oncol. 2006 Aug 20;24(24):3858-64. doi: 10.1200/JCO.2006.05.9055. J Clin Oncol. 2006. PMID: 16921038
-
A prospective neurocognitive evaluation of children treated with additional chemotherapy and craniospinal irradiation following isolated central nervous system relapse in acute lymphoblastic leukemia.Int J Radiat Oncol Biol Phys. 1995 Feb 1;31(3):561-6. doi: 10.1016/0360-3016(94)00432-K. Int J Radiat Oncol Biol Phys. 1995. PMID: 7852120
-
Neurodevelopmental sequelae of pediatric acute lymphoblastic leukemia and its treatment.Dev Disabil Res Rev. 2008;14(3):185-95. doi: 10.1002/ddrr.24. Dev Disabil Res Rev. 2008. PMID: 18924154 Review.
-
The neurodevelopmental sequelae of childhood leukaemia and its treatment.Arch Dis Child. 2010 Nov;95(11):936-40. doi: 10.1136/adc.2008.153809. Arch Dis Child. 2010. PMID: 20980277 Review.
Cited by
-
Evaluation of memory impairment in aging adult survivors of childhood acute lymphoblastic leukemia treated with cranial radiotherapy.J Natl Cancer Inst. 2013 Jun 19;105(12):899-907. doi: 10.1093/jnci/djt089. Epub 2013 Apr 12. J Natl Cancer Inst. 2013. PMID: 23584394 Free PMC article.
-
Attention and executive functioning in children and adolescents treated for high-risk acute lymphoblastic leukemia: A report from the Children's Oncology Group (COG).Pediatr Blood Cancer. 2024 Nov;71(11):e31179. doi: 10.1002/pbc.31179. Epub 2024 Aug 23. Pediatr Blood Cancer. 2024. PMID: 39175358 Clinical Trial.
-
Influence of genetic factors on long-term treatment related neurocognitive complications, and on anxiety and depression in survivors of childhood acute lymphoblastic leukemia: The Petale study.PLoS One. 2019 Jun 10;14(6):e0217314. doi: 10.1371/journal.pone.0217314. eCollection 2019. PLoS One. 2019. PMID: 31181069 Free PMC article.
-
Neurocognitive Consequences of Childhood Leukemia and Its Treatment.Indian J Hematol Blood Transfus. 2018 Jan;34(1):62-69. doi: 10.1007/s12288-017-0846-4. Epub 2017 Jul 4. Indian J Hematol Blood Transfus. 2018. PMID: 29398801 Free PMC article.
-
Neurocognitive Outcomes and Interventions in Long-Term Survivors of Childhood Cancer.J Clin Oncol. 2018 Jul 20;36(21):2181-2189. doi: 10.1200/JCO.2017.76.4696. Epub 2018 Jun 6. J Clin Oncol. 2018. PMID: 29874137 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials